Latest Trials
| EudraCT Number: 2004-000114-40 | Sponsor Protocol Number: CLIC477D2303 | Start Date: 2004-11-19 | ||||||
| Sponsor Name: Novartis Pharma AG | ||||||||
| Full Title: A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of licarbazepine 750-2500 mg/d combined with lithium or valproate in the treatmen... | ||||||||
| Medical condition: Bipolar I disorder, manic and mixed episodes DSM-IV criteria 296.0, 296.4 or 296.6 | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: AT (Prematurely Ended) SK (Prematurely Ended) CZ (Prematurely Ended) | ||||||||
| Trial results: View results | ||||||||